Emerging treatment options for patients with Laron syndrome
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Link
http://www.tandfonline.com/doi/pdf/10.1517/21678707.2014.912581
Reference133 articles.
1. Laron Syndrome (Primary Growth Hormone Resistance or Insensitivity): The Personal Experience 1958–2003
2. Laron Z, Kopchick JJ. editors. Laron syndrome-from man to mouse. Springer-Verlag, Heidelberg, New York; 2011. p. 531
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model;Gene Therapy;2022-02-01
2. Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome;European Journal of Endocrinology;2021-02
3. A 42-Year-Old Woman with Untreated Growth Hormone Insensitivity, Diabetic Retinopathy, and Gene Sequencing Identifies a Variant of Laron Syndrome;American Journal of Case Reports;2019-05-14
4. Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I);Journal of Pediatric Endocrinology and Metabolism;2018-07-11
5. Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report;Italian Journal of Pediatrics;2017-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3